These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3785898)

  • 41. Phaco-emulsification in completely vitrectomized eyes: Intraoperative analysis of modified phaco sleeve.
    Joshi RS
    Indian J Ophthalmol; 2016 Sep; 64(9):659-662. PubMed ID: 27853014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative findings during vitreous surgery after implantation of diffractive multifocal intraocular lens.
    Kawamura R; Inoue M; Shinoda K; Bissen-Miyajima H
    J Cataract Refract Surg; 2008 Jun; 34(6):1048-9. PubMed ID: 18499020
    [No Abstract]   [Full Text] [Related]  

  • 43. Inadvertent Expulsion of Fluocinolone Acetonide Intravitreal Implant during Pars Plana Vitrectomy.
    Wang H; Hardin J; Kaintatzis A; Uwaydat SH; Sallam AB
    Ophthalmol Retina; 2018 Jan; 2(1):75-77. PubMed ID: 31047311
    [No Abstract]   [Full Text] [Related]  

  • 44. Suprachoroidal hemorrhage during pars plana vitrectomy in traumatized eyes.
    Mei H; Xing Y; Yang A; Wang J; Xu Y; Heiligenhaus A
    Retina; 2009 Apr; 29(4):473-6. PubMed ID: 19174724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients.
    Benson WE; Brown GC; Tasman W; McNamara JA
    Ophthalmic Surg; 1988 Dec; 19(12):862-4. PubMed ID: 3231410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage.
    de Bustros S; Glaser BM; Michels RG; Auer C
    Arch Ophthalmol; 1985 Feb; 103(2):219-21. PubMed ID: 3883968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative evaluation of the results of preoperative ultrasonic diagnosis and ophthalmoscopic data acquired at the time of and following vitrectomy in patients with intravitreal hemorrhage].
    Glinchuk IaI; Kiselev AV
    Oftalmol Zh; 1985; (5):267-8. PubMed ID: 3906467
    [No Abstract]   [Full Text] [Related]  

  • 48. Massive suprachoroidal hemorrhage. Follow-up and outcome of 30 cases.
    Welch JC; Spaeth GL; Benson WE
    Ophthalmology; 1988 Sep; 95(9):1202-6. PubMed ID: 3264898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy.
    Woo SJ; Park KH; Hwang JM; Kim JH; Yu YS; Chung H
    Retina; 2009 Apr; 29(4):456-63. PubMed ID: 19174725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pseudohypopyon after vitrectomy for vitreous hemorrhage].
    Zhang S; Gao R; Wu Q
    Zhonghua Yan Ke Za Zhi; 1997 May; 33(3):213-5. PubMed ID: 10437040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vitrectomy for vitreous hemorrhage caused by retinal vein occlusion].
    Liu W; Wang W
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):113-5. PubMed ID: 11835787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of the Cochrane Review: Anti-vascular Endothelial Growth Factor for Prevention of Postoperative Vitreous Cavity Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy. Cochrane Database Syst Rev. 2015;8:CD008214.].
    Sousa DC; Leal I; Costa J; Vaz-Carneiro A
    Acta Med Port; 2017 Aug; 30(7-8):513-516. PubMed ID: 28926323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraocular human thrombin infusion in diabetic vitrectomies.
    Verdoorn C; Hendrikse F
    Ophthalmic Surg; 1989 Apr; 20(4):278-9. PubMed ID: 2733994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
    Mason JO; Gupta SR; Compton CJ; Frederick PA; Neimkin MG; Hill ML; Heersink MJ; Vail RS; White MF; Feist RM; Thomley ML; Albert MA
    Ophthalmology; 2011 Mar; 118(3):543-7. PubMed ID: 20884061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urokinase in the management of vitreous hemorrhage.
    Chapman-Smith JS; Crock GW
    Br J Ophthalmol; 1977 Aug; 61(8):500-5. PubMed ID: 911729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger.
    Wu WC; Chang SM; Chen JY; Chang CW
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):363-71. PubMed ID: 11572467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
    Lee SY; Yoon YH; Lee HG; Chung H; Kim JG
    Am J Ophthalmol; 2006 Sep; 142(3):501-3. PubMed ID: 16935603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative choroidal hemorrhage at pars plana vitrectomy. A case-control study.
    Piper JG; Han DP; Abrams GW; Mieler WF
    Ophthalmology; 1993 May; 100(5):699-704. PubMed ID: 8493013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sub-retinal hemorrhage during internal limiting membrane peeling for a macular hole.
    Nakata K; Ohji M; Ikuno Y; Kusaka S; Gomi F; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):582-584. PubMed ID: 12739175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.